Dow Down0.02% Nasdaq Up0.07%




News & Info


Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates


  • Major Holders
  • Insider Transactions
  • Insider Roster


Dr. Reddy's Laboratories Ltd. (DRREDDY.BO)

3,549.80 Down 16.85(0.47%) 3:47AM EST
ProfileGet Profile for:
Dr. Reddy's Laboratories Ltd.
8-2-337, Road No. 3
Banjara Hills
Hyderabad, 500034
India - Map
Phone: 91 40 4900 2900
Fax: 91 40 4900 2999

Index Membership:N/A
Industry:Drugs - Generic
Full Time Employees:18,421

Business Summary 

Dr. Reddy’s Laboratories Limited operates as an integrated pharmaceutical company in India. It operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment produces and markets finished pharmaceutical products as branded formulations or generic finished dosages. This segment is also engaged in the operation of biologics business. The PSAI segment develops active pharmaceutical ingredients (APIs) and intermediaries, which are used as principal ingredients for finished pharmaceutical products. This segment also offers contract research services to biotech and pharmaceutical companies; and manufactures and sells APIs and steroids in accordance with the specific customer requirements. The Proprietary Products segment is involved in the discovery and development of new chemical entities and differentiated formulations for subsequent commercialization. Its differentiated formulations portfolio consists of new, synergistic combinations, and technologies that enhance safety and/or efficacy by modifying pharmacokinetics of existing medicines. This segment is also involved in the Company’s specialty pharmaceuticals business, which conducts sales and marketing operations for in-licensed and co-developed dermatology products. The company’s therapeutic categories include gastro-intestinal, cardiovascular, pain management, and oncology. It also operates in North America, Europe, Russia, other countries of the former Soviet Union, and internationally. Dr. Reddy’s Laboratories Limited has strategic partnership with GlaxoSmithKline plc to develop and market products outside India; and collaboration agreement with Merck Serono to develop a portfolio of biosimilar compounds in oncology, primarily focused on monoclonal antibodies. The company was founded in 1984 and is headquartered in Hyderabad, India.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Dr. Reddy's Laboratories Ltd.

Key Executives 
Mr. Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.), 54
Co-Chairman, Managing Director, Chief Exec. Officer, Member of The Management Council, Member of Management Committee, Member of Investment Committee, Member of Corp. Social Responsibility Committee and Member of Stakeholders' Relationship Committee
Mr. Kallam Satish Reddy B.Tech., M.S., 47
Chairman of The Board, Member of The Management Council, Chairman of Management Committee, Member of Investment Committee, Member of Corp. Social Responsibility Committee and Member of Stakeholders' Relationship Committee
Mr. Saumen Chakraborty B.Sc. (H), MBA-IIM, 53
Pres, Chief Financial Officer, Global Head of Information Technology & Bus. Process Excellence and Member of the Management Council
Dr. Sripada Chandrasekhar , 57
Pres, Global Head of HR and Member of Management Council
Mr. Abhijit Mukherjee B.Tech. (Chem.), 56
Chief Operating Officer and Member of the Management Council
Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in INR.